Achieve Life Sciences Inc (ACHV)
4.735
+0.04
(+0.96%)
USD |
NASDAQ |
May 03, 16:00
4.735
0.00 (0.00%)
After-Hours: 20:00
Achieve Life Sciences 1 Year Total Returns (Daily): -45.13% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -45.13% |
May 02, 2024 | -46.28% |
May 01, 2024 | -47.38% |
April 30, 2024 | -47.30% |
April 29, 2024 | -45.14% |
April 26, 2024 | -43.37% |
April 25, 2024 | -42.96% |
April 24, 2024 | -43.81% |
April 23, 2024 | -44.10% |
April 22, 2024 | -45.22% |
April 19, 2024 | -35.66% |
April 18, 2024 | -38.08% |
April 17, 2024 | -41.41% |
April 16, 2024 | -39.59% |
April 15, 2024 | -38.62% |
April 12, 2024 | -36.29% |
April 11, 2024 | -35.35% |
April 10, 2024 | -38.31% |
April 09, 2024 | -38.24% |
April 08, 2024 | -38.24% |
April 05, 2024 | -33.53% |
April 04, 2024 | -33.63% |
April 03, 2024 | -36.25% |
April 02, 2024 | -34.12% |
April 01, 2024 | -32.65% |
Date | Value |
---|---|
March 28, 2024 | -18.11% |
March 27, 2024 | -11.89% |
March 26, 2024 | -5.28% |
March 25, 2024 | -5.08% |
March 22, 2024 | -2.13% |
March 21, 2024 | 5.02% |
March 20, 2024 | 6.39% |
March 19, 2024 | 4.83% |
March 18, 2024 | 5.75% |
March 15, 2024 | 0.66% |
March 14, 2024 | -1.55% |
March 13, 2024 | 3.27% |
March 12, 2024 | -2.03% |
March 11, 2024 | -2.03% |
March 08, 2024 | -14.09% |
March 07, 2024 | -13.27% |
March 06, 2024 | -17.50% |
March 05, 2024 | -14.26% |
March 04, 2024 | -13.67% |
March 01, 2024 | -8.11% |
February 29, 2024 | -16.49% |
February 28, 2024 | -8.04% |
February 27, 2024 | -8.72% |
February 26, 2024 | -18.04% |
February 23, 2024 | -21.89% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.36%
Minimum
Mar 16 2020
154.1%
Maximum
Mar 16 2021
-25.77%
Average
-32.16%
Median
Jun 17 2022
1 Year Total Returns (Daily) Benchmarks
Accelerate Diagnostics Inc | -88.74% |
Atossa Therapeutics Inc | 150.6% |
ENDRA Life Sciences Inc | -79.71% |
Perspective Therapeutics Inc | 196.0% |
Electromed Inc | 78.40% |